ArticleImaging neuroscience (Cambridge, Mass.)2025
MRI-scale histology validates spatial sensitivity of in-vivo MRI-based axon radius estimation.
Article in Imaging neuroscience (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The axon radius holds promise as a clinical MRI biomarker for neurological disorders. However, in-vivo MRI estimation appears infeasible on clinical scanners and lacks experimental validation. Crucially, existing histology is only sparsely sampled, enabling primarily qualitative assessment. Here, we use large-scale human brain histology, sampling 46 million axons across 35 corpus callosum regions with MRI-like sizes. By demonstrating a significant spatial correlation with histology on an advanced research scanner, we provide quantitative proof that MRI radius estimates reflect underlying microstructure-a critical milestone. The next milestone-translation to clinical scanners-appears feasible with now-available high-gradient systems according to simulations, but would require substantial SNR gains. Yet, we also identify a sensitivity bottleneck in current modeling that may offer a complementary path to improved sensitivity through future modeling advances. Overall, we provide promising evidence for the validity of MRI-based axon radius estimation and identify challenges that must be solved for clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.